| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
| 06/13/2013 | US20130150585 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof |
| 06/13/2013 | US20130150404 Biphenyl derivatives |
| 06/13/2013 | US20130150401 New compounds, pharmaceutical compositions and uses thereof |
| 06/13/2013 | US20130150390 Therapeutic or prophylactic agent for allergic dermatitis |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | US20130150367 Carboxamide compounds and their use as calpain inhibitors |
| 06/13/2013 | US20130150365 Insecticidal Triazines and Pyrimidines |
| 06/13/2013 | US20130150358 Theramutein modulators |
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
| 06/13/2013 | US20130150355 Novel compounds |
| 06/13/2013 | US20130150354 New selective ccr2 antagonists |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130149283 Methods and compositions for treating hepatitis c virus |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | CA2856654A1 Hydantoin derivatives useful as kv3 inhibitors |
| 06/12/2013 | EP2602257A1 Epoxy compound with nitrogen-containing ring |
| 06/12/2013 | EP2602256A1 Method for producing epoxy compound having cyanuric acid skeleton |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 06/12/2013 | EP2601188A1 Hepatitis c virus inhibitors |
| 06/12/2013 | EP2601185A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
| 06/12/2013 | CN202989024U Production system of isocyanuric acid tri-glycidyl ester |
| 06/12/2013 | CN202984265U Disposal system used for solid salt waste in production of triglycidyl isocyanurate (TGIC) |
| 06/12/2013 | CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use |
| 06/12/2013 | CN103155268A Photoelectric conversion element, pigment for photoelectric conversion element and compound |
| 06/12/2013 | CN103154018A Ligands for antibody and Fc-fusion protein purification by affinity chromatography |
| 06/12/2013 | CN103153986A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/12/2013 | CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | CN103153974A Phenanthro[9,10-B]furans for electronic applications |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103153965A Quinoxaline derivates |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153952A Oxime ester derivatives of benzocarbazole compounds and their use as photoinitiators in photopolymerizable compositions |
| 06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
| 06/12/2013 | CN103145698A Preparation method of Rivaroxaban midbody and novel synthetic method of Rivaroxaban |
| 06/12/2013 | CN103145666A 4-substituted alpha-pyrone derivative as well as preparation method and application thereof |
| 06/12/2013 | CN102276581B N-substituted tetrahydropyridine bound indole compound as well as preparation method and application thereof |
| 06/12/2013 | CN101868448B 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 06/11/2013 | US8461342 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| 06/11/2013 | US8461329 Isoquinoline derivative |
| 06/11/2013 | CA2730511C 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082429A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/06/2013 | WO2013081549A1 Method for preparing 2h-azirine carboxylic esters |
| 06/06/2013 | WO2013081416A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/06/2013 | WO2013080218A1 Novel intermediates and process for the preparation of lapatinib and its pharmaceutically acceptable salts |
| 06/06/2013 | WO2013079578A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013079350A1 Insecticidal triazinone derivatives |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2012074126A9 Bicyclic compound |
| 06/06/2013 | US20130143921 Novel peperidine-flavan alkaloid compounds derived from african herb tea kinkeliba as anti-diabetic agents |
| 06/06/2013 | US20130143918 Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| 06/06/2013 | US20130143905 Novel antagonists for ccr2 and uses thereof |
| 06/06/2013 | US20130143880 Positive allosteric modulators of mglur2 |
| 06/06/2013 | US20130143877 Composition comprising tetracyclic compound |
| 06/06/2013 | US20130143871 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/06/2013 | US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use |
| 06/06/2013 | US20130143841 Benzoheterocyclic anti-bacterial agents |
| 06/06/2013 | US20130142887 Use of histone acetyltransferase inhibitors as novel anti-cancer therapies |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | DE112010005815T5 Bicarbazolverbindungen für OLEDs Bicarbazolverbindungen for OLEDs |
| 06/06/2013 | CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases |
| 06/06/2013 | CA2856839A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | CA2856831A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/06/2013 | CA2856457A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | CA2856453A1 Insecticidal triazinone derivatives |
| 06/06/2013 | CA2850705A1 2- (phenyl or pyrid - 3 - yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | CA2850594A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/05/2013 | EP2600430A1 Organic electroluminescence element |
| 06/05/2013 | EP2599779A1 Dispiro 1,2,4-trioxolane antimalarials |
| 06/05/2013 | EP2599774A1 Condensed ring pyridine compound |
| 06/05/2013 | EP2599386A1 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/05/2013 | EP2598497A1 Cyclic amine azaheterocyclic carboxamides |
| 06/05/2013 | EP2598495A1 Novel derivatives useful as antiviral agents |
| 06/05/2013 | EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 06/05/2013 | EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same |
| 06/05/2013 | EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 06/05/2013 | EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 06/05/2013 | CN103140512A Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 06/05/2013 | CN103140484A Cyclic amine azaheterocyclic carboxamides |
| 06/05/2013 | CN103140483A New heterocyclic compounds as pesticides |
| 06/05/2013 | CN103140478A Process for the synthesis of substituted urea compounds |
| 06/05/2013 | CN103140476A Novel trpv3 modulators |
| 06/05/2013 | CN103130919A Carbazole ketone oxime ester high-photosensibility photoinitiator |
| 06/05/2013 | CN103130782A Method for preparing lafutidine from hydroxylamine hydrochloride |
| 06/05/2013 | CN103130781A Lincosamides antibacterial drug capable of being used for treating bacterial infection |